1,3,4,8-tetrahydro-2H-pyrido[1,2a]pyrazine derivative and use of same as HIV integrase inhibitor

Details for Australian Patent Application No. 2011221037 (hide)

Owner Japan Tobacco Inc.

Inventors Miyazaki, Susumu; Bessho, Yuki; Adachi, Kaoru; Kawashita, Seiji; Isoshima, Hirotaka; Oshita, Kengo; Fukuda, Shunichi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011221037

PCT Pub. Number WO2011/105590

Priority 2010-043567 26.02.10 JP; 61/339,729 09.03.10 US

Filing date 25 February 2011

Wipo publication date 1 September 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5377

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/105590 Priority application(s): WO2011/105590

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011221038-Low-chromium-content stainless steel with excellent corrosion resistance of weld

2011220940-Modulation of angiogenesis